Phillips-Medisize-logoPhillips-Medisize said today that it entered into an agreement with an unnamed biotechnology company to manufacture a wearable, electronic-enabled combination product for subcutaneous drug delivery.

The hockey puck-sized product is designed as a disposable, single-use combination device that can be worn near the infusion site for two days or adhere to the patient’s body with an adhesive patch. It is still under development.

Get the full story at our sister site, Drug Delivery Business News.